LQDA Company Profile and Key Details

LQDA has shown sold momentum, gaining 7.54% over the past week and 75.09% over the past quarter, though year-to-date performance is up 14.12%. Short-term trend indicators are bearishly aligned (SMA20 -20.05%, SMA50 -17.17%, SMA200 18.91%). The stock’s 14-day RSI is 33.73 (weak momentum), while the ATR of 2.71 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -34.03% below its high and over 173.45% above its low. Average 10-day trading volume of 867.93 thousand shares is below the 3-month average of 1.36 million, indicating normal recent market interest.

Liquidia Corporation has 86.09 million shares outstanding. The public float is 59.87 million shares, elevated short interest at 30.75% of float. This equals 21.11 million shares. The short ratio is 8.77 days. Institutional investors hold 81.7% of the float. Insiders own 13.61%. JOHNSON DAVID EDWARD holds 10.64 million shares, Caligan Partners LP has 6.84 million shares and Canaan VIII LP has 2.92 million shares. Over the past six months, insider transactions show net selling. They sold 948.98 thousand shares across 54 transactions.

Liquidia Corporation (NASDAQ:LQDA) closed at $42.28 USD, gaining $0.14 (0.33%) from the previous close of $42.14. The stock is currently mid-range between its 52-week high and low $11.85 and $46.67. With a market capitalization of about $3.73 billion, Liquidia Corporation is classified as a mid-cap and shows lower-than-market volatility (beta ~0.42). Key stats such as the average daily volume over the past year has been around 1.38 million shares, in line with its 52-week average. Headquartered in Morrisville, NC, Liquidia Corporation operates in the Healthcare sector and the Biotechnology industry. Led by CEO Roger A. Jeffs, the company employs approximately 170 people and listed since July 26, 2018. Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States.

Liquidia Corporation generated EPS of -$1.43 over the past year. Five-year average earnings growth is 8.44%. The latest quarter delivered EPS of $0.15. The next quarter is forecast at $0.19. Next year's EPS is expected at -$13.03. Analyst sentiment is bullish. Analyst rating data shows there are 4 Strong Buy ratings, 14 Buy ratings, 0 Hold ratings, 0 Sell rating and 2 Strong Sell ratings. Price targets range from $55.00 to $13.00. The high target offers 30.09% upside. The low target suggests -69.25% downside. The mean target is $42.55. This offers 0.64% upside. Liquidia Corporation earnings surprise history is a consistent trend of beating forecasts. The quarter that ended March 05, 2026, missed forecasts by 87.5%. The prior quarter beat by -91.11%. Over the last six quarters, Apple has recorded several small beats. These include 0.0% in November 13, 2024.

Liquidia Corporation last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$14.78. This means the shares are trading below this model’s fair value.

Liquidia Corporation trades at a P/E ratio of -53.19, slightly below the S&P 500 average, with a price-to-sales ratio of 23.43 and a price-to-book ratio of 81.93 reflecting a rich premium to book value. The P/FCF stands at -92.67, also below market averages. Compared to sector medians, Liquidia Corporation P/S is trading rich, and the P/B is far higher than peers, underscoring the brand and earnings power premium investors assign to the stock.

Liquidia Corporation (NASDAQ:LQDA) shares are up 14.12% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Liquidia Corporation trading at a premium to the broader market with a P/E of -53.19. Analyst sentiment is bullish, with the majority of ratings in Overweight territory and a mean price target of $26.80, suggesting -36.61% downside. Our AI forecast model points to short-term strength (2.32% over two weeks), a medium-term rise (76.25% over three months), and a longer-term gain (23.77% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Liquidia Corporation stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 2.32%, with price expected at $43.26 by May 21, 2026, within a range of $42.02 to $44.53 3-Month Outlook: Projected rise of 76.25%, reaching $74.52 by August 05, 2026, with a range of $73.96 to $74.99. 1-Year Outlook: Projected gain of 23.77%, with price at $52.33 by May 07, 2027, within a range of $49.93 to $54.10.